Sign In
Buy NTRA
$234.76
+5.96 (+2.60%)
At Close: Jun 23, 2026
Natera Reports Fourth Quarter and Full Year 2025 Financial Results
04:05pm, Thursday, 26'th Feb 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the fourth quarter and full year ended Decem
Fox Run Management L.L.C. Buys 3,491 Shares of Natera, Inc. $NTRA
05:08am, Wednesday, 25'th Feb 2026
Fox Run Management L.L.C. boosted its stake in Natera, Inc. (NASDAQ: NTRA) by 42.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. T
Alger SICAV - Alger Dynamic Opportunities Fund Q4 2025 Portfolio Update
02:16pm, Tuesday, 24'th Feb 2026
For the quarter, Alger SICAV - Alger Dynamic Opportunities Fund portfolio's average long exposure was 80.88% and the average short exposure was -32.28%. Long positions MongoDB, Inc., Natera, Inc., and
Successful Readout of Prospective Phase 2 SINERGY Trial Supports SignateraTM MRD-Guided Treatment in Head and Neck Cancer
06:00am, Tuesday, 24'th Feb 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced results from the SINERGY trial, a Phase 2 study in recurrent or me
Unveiling Natera (NTRA) Q4 Outlook: Wall Street Estimates for Key Metrics
10:16am, Monday, 23'rd Feb 2026
Beyond analysts' top-and-bottom-line estimates for Natera (NTRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e
Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks
07:30pm, Saturday, 21'st Feb 2026
One investment is a fast-growing genetic testing company that's now generating cash flow and has a scalable business model. The leading semiconductor foundry's sales are booming on AI-led demand, but
Natera, Inc. $NTRA Shares Purchased by State of New Jersey Common Pension Fund D
04:14am, Wednesday, 18'th Feb 2026
State of New Jersey Common Pension Fund D increased its stake in shares of Natera, Inc. (NASDAQ: NTRA) by 5.7% during the third quarter, according to the company in its most recent disclosure with the
Philippe Laffont's Strategic Exit from CoreWeave Inc: A -2.26% Portfolio Impact
06:18pm, Tuesday, 17'th Feb 2026
Insights into Philippe Laffont (Trades, Portfolio)'s Fourth Quarter 2025 Investment Moves Philippe Laffont (Trades, Portfolio) recently submitted the 13F filin
Alger Mid Cap Growth Fund Q4 2025 Portfolio Update
01:25pm, Tuesday, 17'th Feb 2026
Class A shares of the Alger Mid Cap Growth Fund outperformed the Russell Midcap Growth Index during the fourth quarter of 2025. Cidara Therapeutics, Inc., Natera, Inc., and Abivax were among the top c
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
09:00am, Tuesday, 17'th Feb 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended De
Natera, Inc. $NTRA Stake Reduced by Allianz Asset Management GmbH
06:50am, Friday, 06'th Feb 2026
Allianz Asset Management GmbH decreased its holdings in shares of Natera, Inc. (NASDAQ: NTRA) by 2.3% in the undefined quarter, according to the company in its most recent filing with the Securities a
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
06:00am, Friday, 06'th Feb 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study design
Steven Leonard Chapman Sells 85,299 Shares of Natera (NASDAQ:NTRA) Stock
05:56am, Friday, 06'th Feb 2026
Natera, Inc. (NASDAQ: NTRA - Get Free Report) CEO Steven Leonard Chapman sold 85,299 shares of the company's stock in a transaction dated Monday, February 2nd. The stock was sold at an average price o
Michael Burkes Brophy Sells 6,939 Shares of Natera (NASDAQ:NTRA) Stock
04:40am, Friday, 06'th Feb 2026
Natera, Inc. (NASDAQ: NTRA - Get Free Report) CFO Michael Burkes Brophy sold 6,939 shares of the business's stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an aver
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
11:30am, Tuesday, 03'rd Feb 2026
NTRA submits FDA PMA for Signatera CDx, aiming to guide bladder cancer treatment with MRD testing after positive phase 3 trial results.
